Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial - Related Studies

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

This study has been completed.

Study NCT00512187. Last updated on August 6, 2007. Information provided by Universita di Verona

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Chronic Plaque Psoriasis
		Obesity

2	Additional conditions recognized in this trial
		Psoriasis

3	More general conditions related to this trial
		Body Weight
		Nutrition Disorders
		Overnutrition
		Overweight
		Signs and Symptoms
		Skin Diseases
		Skin Diseases, Papulosquamous

4	Interventions listed in this trial
		low calorie diet

5	Additional drug interventions recognized in this trial
		Cyclosporins

6	More general drug interventions related to this trial
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Universita di Verona